Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
AbCellera Biologics Inc. (ABCL) had Free Cash Flow per Share of $-0.23 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$17.08M |
|
$-34.73M |
|
-- |
|
$17.08M |
|
$66.67M |
|
$-49.59M |
|
$13.24M |
|
$-36.34M |
|
$-36.34M |
|
$-34.73M |
|
$-34.73M |
|
$-34.73M |
|
$-34.73M |
|
$-49.59M |
|
$-42.52M |
|
298.51M |
|
298.51M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$742.14M |
|
$424.02M |
|
$659.92M |
|
$1.40B |
|
$67.02M |
|
-- |
|
$327.96M |
|
$394.99M |
|
$1.01B |
|
$919.01M |
|
$1.01B |
|
298.65M |
|
| Cash Flow Statement Financials | |
$-43.96M |
|
$-23.88M |
|
$2.60M |
|
$183.62M |
|
$119.73M |
|
$-63.89M |
|
$28.99M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-290.24% |
|
-290.24% |
|
-- |
|
-212.74% |
|
-203.27% |
|
$-67.96M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.36 |
|
249.23 |
|
-3.45% |
|
-3.78% |
|
-2.48% |
|
-3.45% |
|
$3.37 |
|
|
Free Cash Flow per Share |
$-0.23 |
$-0.15 |
|